ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE)

Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a Maryland corporation formed in 1994 that has elected REIT status for federal income tax purposes and is included in the S&P 500. As the pioneer of the life science real estate niche, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and technology campuses located in AAA innovation clusters, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. As of December 31, 2022, the company had a total market capitalization of $35.0 billion and a North American asset base of 74.6 million square feet, comprising 41.8 million RSF of operating properties, 5.6 million RSF of Class A properties under construction, 9.9 million RSF of near- and intermediate-term development/redevelopment projects, and 17.3 million SF of future development projects.

Alexandria serves approximately 1,000 tenants, including multinational pharmaceutical firms, biotechnology companies, life science product and medical device makers, digital health and agtech companies, academic and government research institutions, and venture capital firms. Its portfolio includes 64 properties held through consolidated joint ventures and four through unconsolidated joint ventures, with an overall occupancy rate of 94.8% (96% ten-year average) and investment-grade or large-cap tenants representing 48% of total annual rental revenue. The company’s core strategy focuses on developing and redeveloping Class A office/laboratory, agtech, and technology space in high-barrier-to-entry innovation clusters, emphasizing significant pre-leasing before construction and sustainable design (targeting LEED Gold or Platinum certification for new developments).

Alexandria also provides strategic capital through its venture capital platform to life science, agrifoodtech, climate innovation, and technology companies, while maintaining REIT compliance in its non-real estate investment activities. Financially, the company emphasizes balance sheet strength and liquidity through diversified capital sources, prudent leverage, and asset recycling strategies, aiming to maximize long-term shareholder value. Alexandria operates as a single reportable segment and faces competition from other REITs, private equity firms, and institutional investors, though it differentiates itself through its pioneering position and deep industry relationships.

The company also maintains compliance with ADA and environmental regulations, holds various insurance policies including environmental and earthquake coverage, and has not identified material environmental liabilities to date. As of December 31, 2022, Alexandria employed 593 people, with a strong focus on employee well-being, diversity, and development; the company reported low turnover rates (3.6% voluntary, 7.7% total) compared to industry averages, offers comprehensive benefits and mental health resources, and promotes inclusion through its Diversity, Equal Employment Opportunity, and Fair Labor policies. Its executive and senior management teams average 24 years of real estate experience and 12 years with the company, reflecting deep institutional expertise in life science real estate development and operations.